ReachMD

Be part of the knowledge.™

Rare and Orphan Diseases

300

LikeLikedUnlike

Mitochondrial Matters: A Clinician’s Insights on Thymidine Kinase 2 Deficiency
NeuroFrontiers
Mitochondrial Matters: A Clinician’s Insights on Thymidine Kinase 2 Deficiency
- Bruce H. Cohen, MD, FAAN
  Peer
Transformation of Treatment Strategies for ATTR Amyloidosis
Heart Matters
Transformation of Treatment Strategies for ATTR Amyloidosis
Addressing Unmet Needs in Chronic GVHD Care with Preventative & Telemedicine Strategies
Project Oncology®
Addressing Unmet Needs in Chronic GVHD Care with Preventative & Telemedicine Strategies
- Arpita Gandhi, MD, MS
  Peer
Early Intervention Strategies for Chronic GVHD: How to Take a Proactive & Multidisciplinary Approach
Project Oncology®
Early Intervention Strategies for Chronic GVHD: How to Take a Proactive & Multidisciplinary Approach
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  Peer
- Zach DeFilipp, MD
  Peer
Treating Steroid-Refractory Chronic GVHD: How to Transition to Second-Line Therapy
Project Oncology®
Treating Steroid-Refractory Chronic GVHD: How to Transition to Second-Line Therapy
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Ned Waller, MD, PhD, FACP
  Peer
- George Chen, MD
  Peer
Optimizing Outcomes in Steroid-Refractory Chronic GVHD with Early Intervention
Project Oncology®
Optimizing Outcomes in Steroid-Refractory Chronic GVHD with Early Intervention
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Erin Kopp, ACNP-BC
  Peer

Case Management Strategies for Patients with ADPKD – Part 2
CME/CE
Case Management Strategies for Patients with ADPKD – Part 2
- Frederic Rahbari-Oskoui, MD, MSc
  Peer
0.50 credits
Talking Rare: Epidemiology and Pathogenesis of APOL1-Mediated Kidney Disease
CME/CE
Talking Rare: Epidemiology and Pathogenesis of APOL1-Mediated Kidney Disease
- Martin Pollak, MD
  Peer
- Susanne Nicholas, MD, MPH, PhD
  Peer
0.25 credits
Interview with the Investigator
Advances in Chronic Kidney Disease
Interview with the Investigator
- Kristen Nowak, PhD
  Peer
A Patient's Journey with ADPKD
Advances in Chronic Kidney Disease
A Patient's Journey with ADPKD
Personalizing Treatment in Cushing’s Disease
CME/CE
Personalizing Treatment in Cushing’s Disease
- Maria Fleseriu, MD, FACE
  Peer
- Irina Bancos, MD
  Peer
0.25 credits
Normalizing mUFC in Cushing’s Disease
CME/CE
Normalizing mUFC in Cushing’s Disease
- William Mencia, MD, FACEHP, CHCP
  Peer
- Eliza B. Geer, MD
  Peer
0.25 credits

Managing Anemia in Patients With Myelofibrosis
Medical Industry Feature
Managing Anemia in Patients With Myelofibrosis
- Ruben Mesa, MD, FACP, MPN Expert
  Peer
Spleen Volume Reduction & Long-Term Survival in Myelofibrosis
Medical Industry Feature
Spleen Volume Reduction & Long-Term Survival in Myelofibrosis
- Ruben Mesa, MD, FACP, MPN Expert
  Peer
Durable Hct Control in Patients with Polycythemia Vera
Medical Industry Feature
Durable Hct Control in Patients with Polycythemia Vera
- Andrew Kuykendall, MD, MPN Expert
  Peer
Updates from The Long-Term Results from a Trial in Presymptomatic SMA Patients
Medical Industry Feature
Updates from The Long-Term Results from a Trial in Presymptomatic SMA Patients
- Jennifer Caudle, DO
  Peer
- Britton Zuccarelli, MD
  Peer
- Thomas Crawford, MD
  Peer
Rare Bleeding Disorders: The Path to Diagnosis & Treatment
Medical Industry Feature
Rare Bleeding Disorders: The Path to Diagnosis & Treatment
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Jesse Pines, MD
  Peer
- Craig Kessler, MD
  Peer
What You Need to Know About Diagnosing Hereditary Angioedema
Medical Industry Feature
What You Need to Know About Diagnosing Hereditary Angioedema
- John Anderson, MD
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended